anti-EphA2 antibody-IR700 conjugate(Rakuten Medical)

N/A

Report date: 2024/05/13 14:30:20

Base Information

Drug Nameanti-EphA2 antibody-IR700 conjugate(Rakuten Medical)
Drug Alias Nameanti-EphA2-IR700(Rakuten Medical)anti-EphA2 antibody conjugated to IR700(Rakuten Medical)anti-EphA2-IR700 antibody conjugate(Rakuten Medical)RM-0256
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > IR700 payload
Mechanisms of ActionCell death stimulantsPhotosensitizersAnti-Ephrin type-A receptor 2
TargetsEphrin type-A receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRakuten Medical Inc
China Registration ClassN/A

Develop Information

Active CompaniesRakuten Medical Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A